Statistics for A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma
Total visits
views | |
---|---|
A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma | 156 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
nihms945776.pdf | 174 |
Top country views
views | |
---|---|
United States | 113 |
Germany | 6 |
Ukraine | 6 |
Sweden | 5 |
United Kingdom | 3 |
Canada | 2 |
China | 2 |
Russia | 2 |
Vietnam | 2 |
Ireland | 1 |
Malaysia | 1 |
Romania | 1 |
Taiwan | 1 |
Top city views
views | |
---|---|
Wilmington | 47 |
Fairfield | 17 |
Houston | 13 |
Cambridge | 6 |
Kiev | 6 |
Jacksonville | 5 |
Kiez | 5 |
White Plains | 5 |
Stockholm | 4 |
Ann Arbor | 2 |
Beijing | 2 |
Brooklyn | 2 |
Dong Ket | 2 |
Toronto | 2 |
Ashburn | 1 |
Bloomington | 1 |
Bucharest | 1 |
Dublin | 1 |
Gunzenhausen | 1 |
Kista | 1 |
Saint Petersburg | 1 |
San Francisco | 1 |
Scottsdale | 1 |
Seremban | 1 |
Tainan | 1 |
Washington | 1 |